Heritage Pharmaceuticals opens new production facility in New Jersey

The 38,000-square-foot facility brings the total manufacturing area for Heritage to 125,000 square feet. (Heritage Pharmaceuticals)

Heritage Pharmaceuticals, based in East Brunswick, New Jersey, opened a new manufacturing facility that was built using modular cleanroom walls.

The 38,000-square-foot facility brings the total manufacturing area for Heritage to 125,000 square feet. The company expects to increase its total employee count at the site to 225 by early next year.

“We are very excited about this move, as it will enable us to consolidate three geographically separated offices into one ‘campus’ in East Brunswick, facilitating more efficient internal communication,” Scott Delaney, Heritage’s president, said in a statement.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Heritage produces 28 products, including tablets, capsules, soft gels and powders for suspension, with an annualized volume of 2 billion units and packaging of 1.5 million serialized units. 

The new addition has already been approved by Health Canada, European Medicines agency and TGA Australia, the company said.

Suggested Articles

Thermo Fisher Scientific's pharma services group is establishing itself as a gene therapy manufacturer with a $1.7 billion cash deal for Brammer Bio.

The FDA is allowing some drugmakers to exceed the level of risk from a probable cancer-causing impurity in losartan for six months.

CDMOs Cambrex and Ajinomoto Bio-Pharma Services upgraded manufacturing plants, Takeda scored an albumin approval via its Shire deal, and more.